Chong Kun Dang is establishing a clear position in the market for the hyperlipidemia complex Atorvastatin-Ezetimibe complex. This is because MSD's Atozet, the original drug, has been jointly sold since 2016, and there is even a certain insurance called Lipilouzet. Lipilouzet has a higher upper limit than Atozet. According to an industry on the 18th, Lipilouzet has been selling since it was listed as the highest price in April last year.

Lipilouzet is the only item that started at the same price as Atozet, which was the highest price at the time of listing. The same-active ingredients listed on the same day are consignment items produced by Chong Kun Dang, and the drug price is lower than that of Lipilou